雌激素敏感的依赖月经周期的过早腹腔收缩成功地用联合避孕药治疗:一个病例报告
Xi Xia1, Hongli Meng1, Jianbo Li2
1Department of Cardiology, The Affiliated Hospital of Yunnan University, Kunming, People's Republic of China.
Postgraduate medicine
|October 25, 2025
概括
雌激素水平升高可能会增加女性
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 妇科 妇科 妇科 妇科
背景情况:
- 雌激素和女性心律失常之间的关系仍然存在争议.
- 以前的动物研究表明复杂的效应,但人类验证是有限的.
研究的目的:
- 提出一个案例报告,支持这样一个假设:雌激素水平升高会增加女性心律失常的易感性.
- 突出激素诱导的心律失常及其管理的潜力.
主要方法:
- 一个30岁的女性患有周期性心跳的病例报告.
- 诊断包括将症状与月经周期相关联,并排除其他原因.
- 治疗包括激素调节疗法.
主要成果:
- 患者经历了与雌激素水平峰值相关的过早心室收缩 (PVCs).
- 激素治疗 (雌激素和孕激素) 缓解了心,阴经障碍和月经不规则.
- 在5个月的随访期间,心没有复发.
结论:
- 这一案例支持雌激素对心律失常的双相作用,可能在高峰期增加风险.
- 临床医生应考虑在有周期性心跳的妇女中与激素有关的心律失常.
- 激素调节疗法可能是一种有效的治疗方法,需要仔细评估.
相关概念视频
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
464
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
464
Birth Control Methods
5.8K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
5.8K
Hormonal Regulation of the Menstrual Cycle
1.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.4K
Hormonal Control of the Ovarian Cycle
6.4K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
6.4K
Dysrhythmias VI: Management of Dysrhythmias
428
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
428
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.4K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K


